Tiêu đề Obs & Gyne 12-2023 update 1.pdf ✅

SPOT LIGHT ON OBS & GYNE 2024 MCQS BOOK DR FADI QUTISHAT OBS & GYNE 12/2023 MCQs 1 st Edition • For internship doctors, residents and students in medical schools. • For preparation to internship exams, entrance exam for residency in JUH, Royal medical services and Ministry of health of Jordan. • More than 30 frequently tested facts • Past papers exam QUTISHAT FADI, MD 2023/2024
SPOT LIGHT ON OBS & GYNE 2024 MCQS BOOK DR FADI QUTISHAT OBS & GYNE 12/2023 1) Regarding pulmonary embolism, All true except A. Increases with maternal age B. Is a complication of severe iron deficiency anaemia C. Is treated with warfarin in pregnancy D. Maternal tachycardia is an early sign E. S1Q3T3 on ECG is charterstic Explanation In most pregnant patients with VTE, subcutaneous low molecular weight (LMW) heparin is the agent of choice; LMW heparin may be switched to unfractionated heparin in some patients prior to labor. Warfarin and direct oral anticoagulants are generally avoided in pregnancy. The rationale for LMW heparin, suitable agents for patients with acute renal failure or those who need rapid short-term control of anticoagulation.
SPOT LIGHT ON OBS & GYNE 2024 MCQS BOOK DR FADI QUTISHAT This table applies to VTE in pregnant individuals, with the exception of individuals with a prosthetic heart valve, which is discussed separately in UpToDate. Dose level – Prevention typically uses low or intermediate dose, but therapeutic dose may be used for prevention in selected cases (eg, individuals with recurrent unprovoked thrombotic events [with or without hereditary thrombophilia or antiphospholipid antibody syndrome] who are receiving long-term anticoagulation with warfarin or a direct oral anticoagulant such as rivaroxaban 20 mg daily or apixaban 5 mg twice daily). Choice of agent – LMW heparin is recommended for most patients. UFH is used when there may be a need for rapid discontinuation, such as for delivery or perioperatively or in individuals with severely reduced kidney function (eg, CrCl <30 mL/min). Only one heparin product is given at any point in time. Confirm the absence of preservatives (eg, benzyl alcohol) in the heparin product chosen.